From Evan Harris <[email protected]>
Subject Bernie’s ‘Medicare-for-all’ misinformation — learn these facts before this week’s debate
Date January 13, 2020 8:14 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
PRI's Focus on Health Care

View this email in your browser ([link removed])

Bernie’s ‘Medicare-for-all’ misinformation — learn these facts before this week’s debate

Featured on Real Clear Health and Fox News Homepage | Sally C. Pipes
January 12, 2020

And then there’s the disruption “Medicare-for-all” would foist upon patients. Government-dominated systems the world over do not provide unfettered access to free, high-quality health care. They respond to the impossible task of treating an unlimited number of patients with limited resources by rationing care. That results in long wait times.

Read more . . . ([link removed])
[link removed]

Why the Pelosi and Newsom Approaches to Prescription Drugs Won’t Really Help Patients

PRI Next Round Podcast | Wayne Winegarden
January 13, 2020

Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation, breaks down recently-proposed plans in Washington and Sacramento that emphasize price caps and more government control to address prescription drug prices. He discusses the conclusions of his new study on America’s drug pricing challenge, which makes the case that system-wide reforms to improve the complex drug supply chain and increase transparency are what’s needed to lower health care costs.

Listen here. . . ([link removed])

Lies, Damn Lies, and Drug Price Increases

Forbes and Real Clear Health | Wayne Winegarden
January 8, 2020

So, what does all of this mean? Since the list prices are not the actual transaction prices, focusing on the changes in list prices is not helpful for addressing the problems afflicting the costs of drugs. Instead, policy should focus on several core issues that are actually driving the problems.

Read more. . . ([link removed])

============================================================
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
Copyright © 2020 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.

Our mailing address is:
101 Montgomery Street, Suite 1300, San Francisco, CA 94104

Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.
Screenshot of the email generated on import

Message Analysis